Encoded metabolic remodeling amplifies drug resistance in Mycobacterium tuberculosis
This study identifies mutations in the *idsA2* gene in *Mycobacterium tuberculosis* as a mechanism of metabolic remodeling that amplifies ethambutol resistance by increasing the production of a competing lipid substrate, thereby enhancing drug tolerance in strains already harboring primary resistance mutations.